225 related articles for article (PubMed ID: 22984535)
1. Multi-scale biomechanical remodeling in aging and genetic mutant murine mitral valve leaflets: insights into Marfan syndrome.
Gould RA; Sinha R; Aziz H; Rouf R; Dietz HC; Judge DP; Butcher J
PLoS One; 2012; 7(9):e44639. PubMed ID: 22984535
[TBL] [Abstract][Full Text] [Related]
2. Dynamic changes in mitral valve extracellular matrix, tissue mechanics and function in a mouse model of Marfan syndrome.
Gonzalez BA; Harmeyer SW; Song T; Sadayappan S; Yutzey KE
Matrix Biol; 2024 Feb; 126():1-13. PubMed ID: 38185344
[TBL] [Abstract][Full Text] [Related]
3. Fibrillin and other matrix proteins in mitral valve prolapse syndrome.
Nasuti JF; Zhang PJ; Feldman MD; Pasha T; Khurana JS; Gorman JH; Gorman RC; Narula J; Narula N
Ann Thorac Surg; 2004 Feb; 77(2):532-6. PubMed ID: 14759433
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome.
Ng CM; Cheng A; Myers LA; Martinez-Murillo F; Jie C; Bedja D; Gabrielson KL; Hausladen JM; Mecham RP; Judge DP; Dietz HC
J Clin Invest; 2004 Dec; 114(11):1586-92. PubMed ID: 15546004
[TBL] [Abstract][Full Text] [Related]
5. Fibrillin-1 genetic deficiency leads to pathological ageing of arteries in mice.
Mariko B; Pezet M; Escoubet B; Bouillot S; Andrieu JP; Starcher B; Quaglino D; Jacob MP; Huber P; Ramirez F; Faury G
J Pathol; 2011 May; 224(1):33-44. PubMed ID: 21432852
[TBL] [Abstract][Full Text] [Related]
6. Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome.
Emrich FC; Okamura H; Dalal AR; Penov K; Merk DR; Raaz U; Hennigs JK; Chin JT; Miller MO; Pedroza AJ; Craig JK; Koyano TK; Blankenberg FG; Connolly AJ; Mohr FW; Alvira CM; Rabinovitch M; Fischbein MP
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):146-54. PubMed ID: 25359856
[TBL] [Abstract][Full Text] [Related]
7. Successful Mitral Valve Replacement in an Infant with Neonatal Marfan Syndrome due to a Novel Missense Mutation of the FBN1 Gene.
Motonaga T; Ohnishi Y; Okada S; Suzuki Y; Furuta T; Kawamura M; Okayama N; Suehiro Y; Hasegawa S
Int Heart J; 2022 Jul; 63(4):777-781. PubMed ID: 35831148
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome.
Kim AJ; Xu N; Umeyama K; Hulin A; Ponny SR; Vagnozzi RJ; Green EA; Hanson P; McManus BM; Nagashima H; Yutzey KE
Circulation; 2020 Jan; 141(2):132-146. PubMed ID: 31928435
[TBL] [Abstract][Full Text] [Related]
9. Discrete contributions of elastic fiber components to arterial development and mechanical compliance.
Carta L; Wagenseil JE; Knutsen RH; Mariko B; Faury G; Davis EC; Starcher B; Mecham RP; Ramirez F
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2083-9. PubMed ID: 19850904
[TBL] [Abstract][Full Text] [Related]
10. Mitral valve disease in Marfan syndrome and related disorders.
Judge DP; Rouf R; Habashi J; Dietz HC
J Cardiovasc Transl Res; 2011 Dec; 4(6):741-7. PubMed ID: 21866385
[TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders.
Attias D; Stheneur C; Roy C; Collod-Béroud G; Detaint D; Faivre L; Delrue MA; Cohen L; Francannet C; Béroud C; Claustres M; Iserin F; Khau Van Kien P; Lacombe D; Le Merrer M; Lyonnet S; Odent S; Plauchu H; Rio M; Rossi A; Sidi D; Steg PG; Ravaud P; Boileau C; Jondeau G
Circulation; 2009 Dec; 120(25):2541-9. PubMed ID: 19996017
[TBL] [Abstract][Full Text] [Related]
12. Association between fibrillin-1 gene exon 15 and 27 polymorphisms and risk of mitral valve prolapse.
Chou HT; Shi YR; Hsu Y; Tsai FJ
J Heart Valve Dis; 2003 Jul; 12(4):475-81. PubMed ID: 12918850
[TBL] [Abstract][Full Text] [Related]
13. IL-6 regulates extracellular matrix remodeling associated with aortic dilation in a fibrillin-1 hypomorphic mgR/mgR mouse model of severe Marfan syndrome.
Ju X; Ijaz T; Sun H; Lejeune W; Vargas G; Shilagard T; Recinos A; Milewicz DM; Brasier AR; Tilton RG
J Am Heart Assoc; 2014 Jan; 3(1):e000476. PubMed ID: 24449804
[TBL] [Abstract][Full Text] [Related]
14. Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome.
Loeys B; Nuytinck L; Delvaux I; De Bie S; De Paepe A
Arch Intern Med; 2001 Nov; 161(20):2447-54. PubMed ID: 11700157
[TBL] [Abstract][Full Text] [Related]
15. Marfan syndrome and mitral valve prolapse.
Weyman AE; Scherrer-Crosbie M
J Clin Invest; 2004 Dec; 114(11):1543-6. PubMed ID: 15578086
[TBL] [Abstract][Full Text] [Related]
16. Marfan syndrome type II: there is more to Marfan syndrome than fibrillin 1.
Zangwill SD; Brown MD; Bryke CR; Cava JR; Segura AD
Congenit Heart Dis; 2006 Sep; 1(5):229-32. PubMed ID: 18377530
[TBL] [Abstract][Full Text] [Related]
17. Acute mitral regurgitation due to chordal rupture in a patient with neonatal Marfan syndrome caused by a deletion in exon 29 of the FBN1 gene.
Weidenbach M; Brenner R; Rantamäki T; Redel DA
Pediatr Cardiol; 1999; 20(5):382-5. PubMed ID: 10441700
[TBL] [Abstract][Full Text] [Related]
18. Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease.
Hulin A; Moore V; James JM; Yutzey KE
Cardiovasc Res; 2017 Jan; 113(1):40-51. PubMed ID: 28069701
[TBL] [Abstract][Full Text] [Related]
19. Double mutant fibrillin-1 (FBN1) allele in a patient with neonatal Marfan syndrome.
Wang M; Kishnani P; Decker-Phillips M; Kahler SG; Chen YT; Godfrey M
J Med Genet; 1996 Sep; 33(9):760-3. PubMed ID: 8880577
[TBL] [Abstract][Full Text] [Related]
20. Marfan syndrome: new clues to genotype-phenotype correlations.
Ramirez F; Gayraud B; Pereira L
Ann Med; 1999 Jun; 31(3):202-7. PubMed ID: 10442675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
